Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

科达琳 - NMPA Drug Approval Details

Approvals/NMPA/Compound Paracetamol and Phenylephrine Tablets

Approved

化学药品

Compound Paracetamol and Phenylephrine Tablets

幸福醫藥有限公司🇨🇳 National Medical Products Administration

Approval Date: Oct 25, 2024
Approval ID: 8h4wae0an4n
Company: 幸福醫藥有限公司
Type: 化学药品

Approval Details

Approval Id: 8h4wae0an4n
Approval Number: 国药准字HC20140022
Generic Name: 复方氨酚肾素片
Generic Name En: Compound Paracetamol and Phenylephrine Tablets
Trade Name: 科达琳
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含对乙酰氨基酚250mg,无水咖啡因30mg,盐酸去氧肾上腺素5mg,马来酸氯苯那敏2mg,维生素B1 3mg。
Reg Date: 2024-10-25
Expired Date: 2029-10-24
Company Name: 幸福醫藥有限公司
Production Company Address: 香港柴湾嘉业街56号安全货仓工业大厦5楼
Company Detail Path: /organization/xing-fu-yi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 25, 2024

Approval ID

8h4wae0an4n

Type

化学药品

Back to NMPA Approvals